Kinh doanh - Marketing
Kinh tế quản lý
Biểu mẫu - Văn bản
Tài chính - Ngân hàng
Công nghệ thông tin
Tiếng anh ngoại ngữ
Kĩ thuật công nghệ
Khoa học tự nhiên
Khoa học xã hội
Văn hóa nghệ thuật
Sức khỏe - Y tế
Văn bản luật
Nông Lâm Ngư
Kỹ năng mềm
Luận văn - Báo cáo
Giải trí - Thư giãn
Tài liệu phổ thông
Văn mẫu
Giới thiệu
Đăng ký
Đăng nhập
Tìm
Danh mục
Kinh doanh - Marketing
Kinh tế quản lý
Biểu mẫu - Văn bản
Tài chính - Ngân hàng
Công nghệ thông tin
Tiếng anh ngoại ngữ
Kĩ thuật công nghệ
Khoa học tự nhiên
Khoa học xã hội
Văn hóa nghệ thuật
Y tế sức khỏe
Văn bản luật
Nông lâm ngư
Kĩ năng mềm
Luận văn - Báo cáo
Giải trí - Thư giãn
Tài liệu phổ thông
Văn mẫu
Thông tin
Điều khoản sử dụng
Quy định bảo mật
Quy chế hoạt động
Chính sách bản quyền
Giới thiệu
Đăng ký
Đăng nhập
0
Trang chủ
Y Tế - Sức Khoẻ
Y học thường thức
Familial breast cancer - The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
Đang chuẩn bị liên kết để tải về tài liệu:
Familial breast cancer - The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
Hữu Tài
76
50
pdf
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Healthcare professionals should discuss the purpose, duration, frequency and location of follow-up with each man with localised prostate cancer8 , and if he wishes, his partner or carers. Men with prostate cancer should be clearly advised about potential longer term adverse effects and when and how to report them. Men with prostate cancer who have chosen a watchful waiting regimen with no curative intent should normally be followed up in primary care in accordance with protocols agreed by the local urological cancer MDT and the relevant primary care organisation(s). Their PSA should be measured at least once a. | Issue date October 2006 NHS National Institute for Health and Clinical Excellence Familial breast cancer This is a partial update of NICE clinical guideline 14 NICE clinical guideline 41 Developed by the National Collaborating Centre for Primary Care The classification and care of women at risk of familial breast cancer in primary secondary and tertiary care NICE clinical guideline 41 Familial breast cancer the classification and care of women at risk of familial breast cancer in primary secondary and tertiary care Ordering information You can download the following documents from www.nice.org.uk CG041 The NICE guideline this document - all the recommendations. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - information for patients and carers. The full guideline - all the recommendations details of how they were developed and summaries of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance phone the NHS Response Line on 0870 1555 455 and quote N1130 quick reference guide N1131 Understanding NICE guidance . This guidance is written in the following context This guidance represents the view of the Institute which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. The guidance does not however override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer. National Institute for Health and Clinical Excellence MidCity Place 71 High Holborn London WC1V 6NA www.nice.org.uk National Institute for Health and Clinical Excellence October 2006. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial
TÀI LIỆU LIÊN QUAN
Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: Protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer
Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women
Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: Systematic review and meta-analysis
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan
The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
BRCA2 carriers with male breast cancer show elevated tumour methylation
Identification of candidate cancer predisposing variants by performing wholeexome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Predictors of mammographic density among women with a strong family history of breast cancer
Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.